The Most Advanced FDA-Inspected Biolabs
Navigating the complexities of bringing new drugs to market requires partnering with the industry experts.
Australian-based Agilex Biolabs is recognised as the APAC region’s leader in bioanalytical excellence.
We deliver quality every time, for every project.
Like you, we are passionate about accelerating your drug to market.
We offer specialised expertise in regulated bioanalysis and the highest level of scientific innovation, customer service, data integrity and quality assurance.
World-Class Customised Equipment
With 20 years of experience in performing regulated bioanalysis, including quality method development, method validation and sample analysis services, we have successfully supported hundreds of preclinical and clinical trials around the world.
Our FDA-inspected Australian bioanalytical facilities have OECD GLP recognition with NATA and ISO 17025 Accreditation with NATA. Technical work is performed to meet FDA and EMA guidelines, providing our clients with a globally accepted basis for drug approval. Our global client base includes the leading pharmaceutical and biotech companies in Asia, Europe and the USA.
When you partner with Agilex Biolabs, you can be confident that your project will be delivered by the experts on time and with the highest quality results.
Our Platform Suite:
- LC – MS/MS Bioanalysis
- Immunoassay Bioanalysis
We offer a range of services on regulated bioanalysis of small and large molecules
We know that for successful bioanalysis, scientific expertise and world-class technology go hand in hand. Our dedicated laboratory scientists are experts in performing regulated bioanalysis using LC-MS/MS and immunoassay platforms.
This specialised expertise allows us to identify the best assay methodology to meet the clinical and regulatory needs for each project, for each client. Our platform suite can meet the diverse assay requirements for regulated bioanalysis.
Please fill in this form and we will be in contact shortly: